Home -> Law Blog Directory -> Patent Law Blogs -> Patent Baristas
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: Patent BaristasPharmaceutical Patent Law: A Prescription for Success in Challenging Times
By Stephen Albainy-Jenei
BNA, the leading provider of expert information and analysis, presents a one-day, information-packed conference entitled Pharmaceutical Patent Law: A Prescription for Success in Challenging Times.
The conference with be held at the Ritz-Carlton, Pentagon City, 1250 South Hayes Street, Arlington, VA, on November 12, 2008.
BNA offers a prescription for success as legislative, judicial, administrative, and ‘marketplace’ developments continue to advance at breakneck speed. This conference will help you:
* Get maximum value from your patents.
* Learn winning litigation tactics from leading practitioners.
* Avoid antitrust consequences when settling cases.
* Look for trends– where does case law go from here?
Recent case law developments, the 2003 Medicare Modernization Act, and even the 2007 FDA Amendments Act have changed the landscape for drug companies that defend or challenge patents. As brand-name companies strive to maximize the market exclusivity for their products, generic makers try to enter the market before patents expire.
This conference will address the possibility of using International Trade Commission procedures to protect drugs from inappropriate competition and strategies for generic companies to challenge patents. In past years, generic companies had been losing the battle to secure court jurisdiction through declaratory judgment actions. However, the Supreme Court decision in the MedImmune case and its recent progeny in the Federal Circuit may have changed the prospects of generic companies on standing issues– for good.
Professionals who work with both branded and generic companies will be eager to hear the FTC Commissioner discuss how to settle patent litigation while staying on the right side of the antitrust laws.
*Special Patent Baristas Discount
Since I will be on a panel discussion of Non-Patent Marketing Exclusivity — with Brian McCormick of Hogan & Hartson, Kurt Karst of Hyman, Phelps & McNamara, and Shashank Upadhye of Apotex — BNA is offering Patent Baristas’ readers a 40% discount off of the registration and, if you sign up two people at the discounted rate, the the third person is free!
To register go to the BNA site and enter the code [CONF40NE].
Click here to view conference information.
Full post as published by Patent Baristas on October 08, 2008 (boomark / email).
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.
Cell Phone Use
Can Increase Risk of Brain Cancer 5 Times
DRAM Patent
ProMOS Technologies and Mosel Vitelic pay MOSAID Technologies an undisclosed patent infringement settlement.
Online Medication Sites
Prescription Drugs Sold Without Prescriptions
Negligent Death
Family of New York Times reporter awarded undisclosed settlement for medical malpractice.

ACI Maximizing Pharmaceutical Patent Lifecycles Conference
Our Daily Meds: This New Book is an Eye-Opener
ACI "Maximizing Pharmaceutical Patent Life Cycles" Conference, New York, October 15-16
PLI Developments in Pharmaceutical and Biotech Patent Law Seminar








